SCHEMBL10070523

SCHEMBL10070523

Cc1ccc(C2OC(C)O2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.40
TDP1 Q9NUW8 1/20 0.40
MAPT P10636 2/20 0.38
ATM Q13315 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
CYP2D6 P10635 1/20 0.34
LMNA P02545 3/20 0.33
ALDH1A1 P00352 4/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR2B P41595 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13356499 0.93 ACHE (0.35) ACHETDP1MAPTATMNPSR1
SCHEMBL8357649 0.78 MAPT (0.38) ACHETDP1MAPTMEN1KMT2A
SCHEMBL12053511 0.78 IDO1 (0.37) ACHEATM
SCHEMBL12641893 0.78 LMNA (0.32) LMNA
SCHEMBL12621700 0.78 ESR2 (0.43) ACHEMAPTMEN1KMT2ACYP3A4
SCHEMBL5704436 0.78 CYP2A6 (0.38) MAPTMEN1KMT2ACYP3A4CYP2C9
SCHEMBL10070998 0.78 LMNA (0.32) LMNA
SCHEMBL13023901 0.78 MAPK1 (0.41) MAPTNPSR1LMNAALDH1A1ELANE
SCHEMBL13356510 0.77 MEN1 (0.48) MEN1KMT2ACYP2C19LMNAHTR2B
SCHEMBL29926357 0.76 ACHE (0.47) ACHETDP1MAPTATMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2502898-A1 PREPARATION METHOD FOR AROMATIC DIFLUOROACETIC ACID ESTER Central Glass Company, Limited (JP) 2012-09-26 EP disclosed
WO-2012085168-A1 ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2012-06-28 WO disclosed
US-7592347-B2 Piperazine derivates and their use for the treatment of neurological and psychiatric diseases GLAXO GROUP LIMITED (GB) 2009-09-22 US disclosed
EP-1882684-A1 PYRROLIDINE DERIVATIVE OR SALT THEREOF Astellas Pharma Inc. (JP) 2008-01-30 EP disclosed